Jump Financial, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 276 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jump Financial, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,714,323
-6.9%
37,276
-27.3%
0.07%
-16.5%
Q1 2022$1,842,000
+174.5%
51,304
+78.1%
0.08%
+88.1%
Q4 2021$671,000
+47.1%
28,800
+20.0%
0.04%
+27.3%
Q3 2021$456,000
-40.0%
24,000
-36.3%
0.03%
-54.8%
Q2 2021$760,00037,7000.07%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Summit Global Investments 58,640$870,0000.13%
FEDERATED HERMES, INC. 2,600,120$38,586,0000.11%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 284,328$4,219,0000.07%
SILVERCREST ASSET MANAGEMENT GROUP LLC 291,352$4,324,0000.05%
MARSHALL WACE, LLP 301,910$4,481,0000.04%
MARTINGALE ASSET MANAGEMENT L P 212,817$3,159,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 171,266$2,542,0000.03%
WINTON GROUP Ltd 82,402$1,223,0000.03%
EAGLE ASSET MANAGEMENT INC 317,988$4,718,0000.03%
Engineers Gate Manager LP 24,007$356,0000.03%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders